Company intelligence / Profile preview

ViroGates

Ballerup/North of Copenhagen ("Medicon Valley"), Denmarkvirogates.com ↗

Ownership: Private
Development stage: Commercial

Overview

ViroGates’ suPARnostic® product line has been validated in over 900 publications. The test enables rapid measurement of the suPAR biomarker to support triage decisions in emergency departments. Clinical implementation has demonstrated faster patient discharge, reduced readmissions and unnecessary admissions, shorter hospital stays, and improved resource utilization. The company’s products are approved for use on major clinical chemistry analyzers with results delivered in under 20 minutes. No therapeutic trials; all data relate to diagnostic performance.

Therapeutic areas: Immunology
Modalities: Device (diagnostic device)Protein biomarker assay (suPARnostic® measures soluble urokinase plasminogen activator receptor)
Industry: Protein Biomarker Diagnostics

Drug pipeline

3 assets

suPARnostic TurbiLatex

Commercial

Indications: Emergency triage, Sepsis, COVID-19, Longevity assessment

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on ViroGates.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ViroGates.

Explore the full profile